PharVision Advisers’s Frontier Group Holdings ULCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.7K Buy
+12,338
New +$78.5K 2.99% 10
2026
Q1
– Sell
-96,681
Closed -$455K – 621
2025
Q4
$455K Buy
+96,681
New +$428K 0.23% 66

Other funds holding ULCC

PharVision Advisers's ULCC Position: Q3 2026 in Review

PharVision Advisers opened a new position in Frontier Group Holdings (ULCC) in Q3 2026: 12,338 shares worth $73.7K. The stake represents 2.99% of the portfolio and ranks #10 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in ULCC as recently as Q4 2025.

PharVision Advisers first reported a position in ULCC in Q4 2025 and has held it in 2 quarters since. The position peaked at $455K in Q4 2025. 37 funds tracked by Wall St. Rank hold ULCC as of Q3 2026.

  • PharVision Advisers held 12,338 shares of Frontier Group Holdings worth $73.7K as of Q3 2026.
  • Frontier Group Holdings was a new PharVision Advisers position in Q3 2026.
  • Frontier Group Holdings made up 2.99% of PharVision Advisers's portfolio in Q3 2026, its #10 holding.
  • PharVision Advisers first reported a position in Frontier Group Holdings in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Frontier Group Holdings position peaked at $455K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Frontier Group Holdings as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.